Susan E Davidson
Overview
Explore the profile of Susan E Davidson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
692
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
White K, Henson C, Hann M, Eden M, Burden S, Lal S, et al.
BMJ Open Gastroenterol
. 2020 Aug;
7(1).
PMID: 32771983
Objective: Pelvic radiotherapy is used to treat 17 000 people in the UK each year. Eight in 10 develop difficult bowel problems during pelvic treatment, especially diarrhoea, urgency and incontinence....
2.
van den Blink Q, Garcez K, Henson C, Davidson S, Higham C
Cochrane Database Syst Rev
. 2018 Apr;
4:CD010604.
PMID: 29683475
Background: Pelvic radiotherapy is a treatment delivered to an estimated 150,000 to 300,000 people annually across high-income countries. Fractures due to normal stresses on weakened bone due to radiotherapy are...
3.
Lawrie T, Green J, Beresford M, Wedlake L, Burden S, Davidson S, et al.
Cochrane Database Syst Rev
. 2018 Jan;
1:CD012529.
PMID: 29360138
Background: An increasing number of people survive cancer but a significant proportion have gastrointestinal side effects as a result of radiotherapy (RT), which impairs their quality of life (QoL). Objectives:...
4.
Dickie B, Rose C, Kershaw L, Withey S, Carrington B, Davidson S, et al.
Br J Cancer
. 2017 Apr;
116(11):1436-1443.
PMID: 28449009
Background: The microvascular contrast agent transfer constant K has shown prognostic value in cervical cancer patients treated with chemoradiotherapy. This study aims to determine whether this is explained by the...
5.
Henson C, Burden S, Davidson S, Lal S
Cochrane Database Syst Rev
. 2013 Nov;
11):CD009896.
PMID: 24282062
Background: Across the developed world, an estimated 150,000 to 300,000 people are treated annually with pelvic radiotherapy and 80% will develop gastrointestinal (GI) symptoms during treatment. Acute GI symptoms are...
6.
Henson C, Anandadas C, Barraclough L, Swindell R, West C, Davidson S
J Natl Compr Canc Netw
. 2013 Jul;
11(7):827-33.
PMID: 23847219
Bowel toxicity is a major complication of cancer treatment, and its accurate reporting is important for assessing outcomes. The NCI's Common Terminology Criteria for Adverse Events (CTCAE) is the preferred...
7.
Henson C, Davidson S, Ang Y, Babbs C, Crampton J, Kelly M, et al.
Support Care Cancer
. 2013 Mar;
21(8):2255-65.
PMID: 23512314
Purpose: Fifty percent of patients develop chronic gastrointestinal (GI) symptoms following pelvic radiotherapy that adversely affect quality of life. Fewer than 20 % are referred to a gastroenterologist. We aimed...
8.
Barraclough L, Routledge J, Farnell D, Burns M, Swindell R, Livsey J, et al.
Radiother Oncol
. 2012 May;
103(3):327-32.
PMID: 22633812
Background And Purpose: As late radiotherapy toxicity impacts negatively on the quality-of-life of cancer survivors and is often under reported, a study was set up to prospectively collect patient-reported data...
9.
Andreyev H, Davidson S, Gillespie C, Allum W, Swarbrick E
Gut
. 2011 Nov;
61(2):179-92.
PMID: 22057051
Background: The number of patients with chronic gastrointestinal (GI) symptoms after cancer therapies which have a moderate or severe impact on quality of life is similar to the number diagnosed...
10.
Anandadas C, Clarke N, Davidson S, OReilly P, Logue J, Gilmore L, et al.
BJU Int
. 2010 Nov;
107(11):1762-8.
PMID: 21083643
Study Type: Preference (prospective cohort). Level Of Evidence: 1b. What's known on the subject? and What does the study add? In general the literature suggests that there is a need...